Netakimab (BCD 085) is a humanized camel-derived monoclonal antibody targeting interleukin-17A, which can be used to study spondyloarthritis and plaque psoriasis.
Purity:
>95%
CAS Number:
[1796570-08-5]
Target:
IL Receptor|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted